Subunit vaccines are safer but less immunogenic than live-attenuated vaccines or whole cell
inactivated vaccines. Adjuvants are used to enhance and modulate antigen (Ag) …

Nanotechnology provides an excellent platform for the development of a new generation of
vaccines. These are based on purified subunit proteins or polysaccharides, recombinant …

Undoubtedly the applications of polymers are rapidly evolving. Technology is continually
changing and quickly advancing as polymers are needed to solve a variety of day-to-day …

Outbreaks and the rapid transmission of viruses, such as coronaviruses and influenza
viruses, are serious threats to human health. A major challenge in combating infectious …

CAB51, a compact antibody against human epithelial growth receptor 2 (HER2, ErbB2), has
been linked to cationic Solid Lipid Nanoparticles (SLN) via streptavidin-biotin interaction and …

New vaccine formulations are still highly anticipated in the near-future to face incoming
health challenges, such as emergence or reemergence of severe infectious diseases …

Despite numerous efforts, we still do not have prophylactic vaccines for many clinically
relevant viruses, such as HIV, hepatitis C virus, Zika virus, and respiratory syncytial virus …

Effective cancer therapy aims to treat not only primary tumors but also metastatic and
recurrent cancer. Immune check point blockade-mediated immunotherapy showed …

Influenza viruses cause seasonal epidemics and represent a pandemic risk. With current
vaccine methods struggling to protect populations against emerging strains, there is a …

The vast majority of seasonal influenza vaccines administered each year are derived from
virus propagated in eggs using technology that has changed little since the 1930s. The …